Results for “Biotech” 9 results

All 9 Health 6 Economy 1 Society 1 Tech 1
AI Virus Design Splits U.S. Biotech Funding Calculus
Health 11 Aug 2026
AI Virus Design Splits U.S. Biotech Funding Calculus
Synthetic pathogen breakthroughs force investors to weigh profit against biosafety risk
Personalized Cancer Vaccine Trial Reshapes U.S. Oncology Race
Society 20 Aug 2026
Personalized Cancer Vaccine Trial Reshapes U.S. Oncology Race
Silicon Valley biotech firms eye licensing rights as NIH weighs funding priorities
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Health 09 Jun 2026
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Ozempic and Wegovy-related muscle loss is spurring a major drug development race, with analysts predicting a $50+ billion market …
AI-Designed Vaccine Reaches U.S. Clinical Pipeline
Health 07 Jun 2026
AI-Designed Vaccine Reaches U.S. Clinical Pipeline
AI-designed vaccine candidate enters U.S. clinical trial pipeline following development at the University of Cambridge, signaling…
America's China Tech Decoupling: Semiconductors, AI, and the New Cold War
Tech 12 May 2026
America's China Tech Decoupling: Semiconductors, AI, and the New Cold War
Washington is systematically severing the technology ties that once bound the world's two largest economies — and the restructuri…
HPV Vaccine Success Pressures U.S. to Close Coverage Gaps
Health 21 Jun 2026
HPV Vaccine Success Pressures U.S. to Close Coverage Gaps
Cervical cancer deaths plummet in England after HPV vaccine implementation, highlighting critical coverage gaps in the U.S. prote…
Havana Syndrome Payouts Spark Push for Neurological Research Fund
Health 12 Jul 2026
Havana Syndrome Payouts Spark Push for Neurological Research Fund
Congress eyes dedicated budget after $3M settlements expose gaps in federal care
Ozempic Maker's Ad War Signals New Front in U.S. Weight-Loss Market
Economy 22 Jul 2026
Ozempic Maker's Ad War Signals New Front in U.S. Weight-Loss Market
Novo Nordisk's suit against Eli Lilly could reshape pharma marketing rules
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Health 14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
Topics: NHS Policy Ukraine War NHS Net Zero Starmer Zero League Artificial Intelligence Ukraine Senate Russia Champions Champions League Mental Health Renewable Energy Final Bill Grid Block Target Energy Security Council